Showing results (1-10 of 60) with videos related to
Sort By:
Pageof 6
Seminars in Immunopathology|May 19, 2021
What does elevated TARC/CCL17 expression tell us about eosinophilic disorders?Julien Catherine, Florence RoufosseJournal of Leukocyte Biology|July 6, 2024
Hypereosinophilic syndrome response to mepolizumab in the setting of a compassionate use programGauthier Coussement, Julien Catherine, Florence RoufosseThe Journal of Allergy and Clinical Immunology|January 9, 2025
Mepolizumab in patients with lymphoid-variant hypereosinophilic syndrome: A multicenter prospective studyJulien Catherine, Sina Karimi, Laurent Dewispelaere, et al.Immunology and Allergy Clinics of North America|July 27, 2015
Management of Hypereosinophilic SyndromesFlorence RoufosseFrontiers in Medicine|April 24, 2018
Targeting the Interleukin-5 Pathway for Treatment of Eosinophilic Conditions Other than AsthmaFlorence RoufosseAdvances in Therapy|September 2, 2019
Oral Corticosteroid Use for the Treatment of Chronic Eosinophilic Disease: A Patient's and His Physician's ExperienceMitchell Silva, Florence RoufosseExpert Review of Hematology|July 12, 2012
Clinical management of the hypereosinophilic syndromesElie Cogan, Florence RoufosseThe Journal of Allergy and Clinical Immunology|June 12, 2010
Practical approach to the patient with hypereosinophiliaFlorence Roufosse, Peter F WellerSeminars in Respiratory and Critical Care Medicine|April 14, 2006
Hypereosinophilic syndrome: lymphoproliferative and myeloproliferative variantsFlorence Roufosse, Michel Goldman, Elie CoganAnnual Review of Medicine|January 15, 2003
The hypereosinophilic syndrome revisitedFlorence Roufosse, Elie Cogan, Michel GoldmanPageof 6